PlainRecalls
FDA Drug Moderate Class II Ongoing

Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13

Reported: April 9, 2025 Initiated: March 17, 2025 #D-0306-2025

Product Description

Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13

Reason for Recall

Failed dissolution specifications: lower than specifications

Details

Recalling Firm
BIOCON PHARMA INC
Units Affected
2184 bottles
Distribution
U.S.A. nationwide
Location
ISELIN, NJ

Frequently Asked Questions

What product was recalled?
Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13. Recalled by BIOCON PHARMA INC. Units affected: 2184 bottles.
Why was this product recalled?
Failed dissolution specifications: lower than specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on April 9, 2025. Severity: Moderate. Recall number: D-0306-2025.